ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Non-Surgical GentleCure™ Treatment Cures 50,000th Skin Cancer Patient

By: NewsUSA

(NewsUSA) -            Fifty thousand people in the U.S. have had their skin cancer cured without going to hospitals or undergoing traditional Mohs surgery, avoiding that treatment’s pain, bleeding, surgical scarring and, often, need for follow-up reconstructive surgery.

          The nation’s 50,000th case of curing common (nonmelanoma) skin cancer with GentleCure™, the non-surgical treatment using Image-Guided Superficial Radiation Therapy or Image-Guided SRT, occurred at Reading Dermatology, the private Pennsylvania practice of Jason Hendrix, DO.

          The patient was Jeffrey Keating, D.P.M., a 74-year-old retired podiatrist from Birdsboro, Pennsylvania, whose lifelong habits of golfing, sailing and driving in his top-down convertible likely contributed to his history of skin cancer.

          “I had Mohs surgery years earlier for a lesion on my calf,” Keating said, “but this time, with three lesions on my face, my doctor and I chose non-surgical GentleCure and the results were outstanding.”

          With GentleCure, doctors treat nonmelanoma skin cancer (basal and squamous cell carcinomas) using ultrasound imaging to direct low-level X-ray energy to targeted areas of the skin, killing cancer cells without surgery. Research shows that the technology produces a 99.3 percent cure rate for early stage nonmelanoma skin cancer, making it just as effective as Mohs surgery, and treatments are covered by Medicare and most insurance plans.

          Dr. Hendrix noted, "More than three million Americans are diagnosed with nonmelanoma skin cancer each year, making it the most common form of cancer. Sun exposure is the primary cause and year-round sun effects are cumulative over one's lifetime, so those who spend a lot of time outdoors plus seniors, those with light skin, users of tanning beds and people with family histories of skin cancer are especially susceptible. With all its advantages, GentleCure is the new non-invasive standard of care."

           Patient Keating added, “As a physician myself, I know that it’s critically important for patients to understand all their treatment options. Having experienced Mohs surgery, the idea of no pain or scarring with GentleCure was very attractive. Actually seeing the cancer shrink and disappear on the ultrasound imaging screen was so reassuring. I have a friend who had Mohs surgery on a facial lesion, and he had a flap of skin cut from his scalp and stretched over the site of his excised lesion; that was not something I wanted to experience. Today, I am fully cured and could not be happier with the GentleCure process and results.”

           For more information and to learn where Image-Guided SRT is available, visit GentleCure.com.

 

 

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.